Skip to main content

Acurx Pharmaceuticals, Inc 8-K, filed Nov 13, 2026

Acurx Pharmaceuticals, Inc. (ACXP)

8-K 2026-11-13 For: 2026-11-12
View Original
Added on November 14, 2026

About this 8-K

Acurx Pharmaceuticals, Inc filed this 8-K on November 13, 2026, reporting on events of November 12, 2026.

Joseph C. Scodari will retire from Acurx Pharmaceuticals, Inc.’s Board effective November 13, 2026, then continue as a corporate advisor. His departure stems from no disagreement over operations, policies or practices. AI summary

Items reported

  • Item 5.02: Director or officer change, or executive pay